Company Name
Shanghai Reinnomed Medical Technology Co., Ltd.
Company Introduction
Shanghai Reinnomed Medical Technology Co., Ltd. originated from the medical-engineering interdisciplinary innovation ecosystem of the University of Shanghai for Science and Technology. The company is built upon long-term research foundations established by the USST–SJTU School of Medicine Medical-Engineering Research Institute and the Shanghai High-End Medical Equipment Innovation Center.
Reinnomed focuses on bridging the systemic gap between engineering technology and clinical medicine. By adopting system engineering as its core R&D methodology, the company models, analyzes, and controls surgical energy behavior, transforming it into stable, predictable, and consistent energy systems to support safer, more precise, and controllable surgical procedures.
Size (number of persons)
50
Official website
www.reinnomed.com
Contact person
Tang Yiyang
Contact email
ian@reinnomed.com
Product Name
- Ultrasonic Scalpel Systems
- Radiofrequency Tumor Ablation Systems
- HIFU Treatment System
- Ultrasonic Bone Knife Systems
- Veterinary Intelligent Electrosurgical Generator with Vessel Sealing System
Product Introduction + Highlights
- The RSG-100 Ultrasonic Soft Tissue Surgical System utilizes high-frequency mechanical vibration to efficiently convert electrical energy into controlled ultrasonic energy, enabling precise tissue cutting with simultaneous coagulation. The low-temperature frictional heat generated during operation, combined with protein denaturation, helps minimize thermal spread and supports clear surgical visibility and tissue preservation.
The system features an intuitive side-button energy control design, allowing surgeons to adjust output in real time according to procedural rhythm. In addition, adaptive frequency-tracking technology enables the RSG-100 to maintain optimal operating conditions under varying tissue impedance, ensuring consistent energy delivery and predictable performance across a wide range of surgical applications. - The RFA-100 Radiofrequency Ablation System is designed to address a key clinical limitation of conventional RF ablation—the lack of precise control over ablation boundaries. The system utilizes both tissue impedance and temperature as dual feedback variables and integrates a closed-loop control algorithm to comprehensively characterize tissue conditions in real time and dynamically optimize power output during ablation.
By establishing a more stable and predictable energy delivery process, the RFA-100 improves the controllability and consistency of ablation margins while reducing operator dependency. This system-level approach supports the advancement of tumor ablation procedures toward greater standardization, precision, and automation, thereby enhancing procedural safety and overall treatment efficiency. - The Ultrasound Aesthetic Medical Treatment System is based on focused ultrasound technology, enabling precise control of energy delivery pathways, treatment depth, and exposure time to selectively target tissue under non-invasive or minimally invasive conditions. By generating predictable energy effects at specific subcutaneous layers, the system supports tissue remodeling and functional improvement while minimizing unnecessary impact on superficial structures.
Designed with a system-oriented energy management and safety control architecture, the platform offers multi-parameter adjustment and real-time monitoring to ensure consistent and reproducible treatment performance. This approach reduces operator dependency and enhances procedural safety and standardization, providing a reliable ultrasound-based solution for a wide range of facial and body aesthetic medical applications. - The Ultrasonic Bone Surgery System operates on the principle of selective interaction between ultrasonic vibration and tissue mechanical properties, enabling efficient bone cutting while minimizing unintended impact on surrounding soft tissues, blood vessels, and neural structures. By precisely controlling vibration frequency, amplitude, and energy output, the system delivers stable and controllable cutting performance, supporting high cutting accuracy and enhanced intraoperative safety.
Designed with a system-oriented energy management architecture and multiple safety protection mechanisms, the platform helps reduce thermal and mechanical injury risks during bone procedures. Its consistent and predictable performance improves surgical visibility and workflow, supporting more precise and standardized bone-related surgical applications across various clinical disciplines. - The EP-200 Intelligent Electrosurgical Energy Platform is designed to meet the demands of modern operating rooms for versatile and integrated energy applications. The system supports multiple operating modes, including monopolar, bipolar, and intelligent vessel sealing, enabling systematic management of tissue cutting, coagulation, and vessel closure.
Based on real-time tissue state sensing and dynamic energy regulation, the EP-200 continuously controls power output to maintain stable and consistent performance across varying tissue conditions. The platform incorporates system-level safety features, including return electrode monitoring and multiple protection mechanisms, to reduce the risk of energy misuse and enhance procedural safety. With an intuitive user interface and standardized operating logic, the EP-200 helps reduce operator dependency and supports efficient, reproducible surgical workflows across a wide range of clinical applications.
Can the products be experienced on-site?
YES
Are the products certified in Thailand and Malaysia?
NO
Is the product leading in the industry?
YES
Have the products been exported to Europe, America or other countries?
Vietnam, Kenya, Tanzania
Demand for Exhibits
Find distributor